CreatorDB | $47,000,000 | (Sep 17, 2025)
Vega(US) | $65,000,000 | (Sep 17, 2025)
Eve Security | $3,000,000 | (Sep 17, 2025)
Certified by Founder
Lodge
NETRIS Pharma
start up
France
- Lyon, Rhône-Alpes
- 20/12/2023
- Series A
- $8,223,000
Our collaborators and partners are driven by a desire to contribute to the development of new ways of fighting cancer. The therapies developed by NETRIS Pharma are based on cellular mechanisms identified by a world-renowned research group.
Located in Léon Bérard Cancer Center (Lyon, France), NETRIS Pharma is a unique model of a biotechnology company integrated within a comprehensive cancer center.
- Industry Pharmaceutical Manufacturing
- Website https://www.netrispharma.com/
- LinkedIn https://www.linkedin.com/company/netris-pharma/about/
Ethosphere | $2,500,000 | (Sep 17, 2025)
Trially AI | $4,700,000 | (Sep 17, 2025)
Bubo² | $2,000,000 | (Sep 17, 2025)
AllRock Bio | $50,000,000 | (Sep 17, 2025)
Overmind | $6,000,000 | (Sep 17, 2025)
BIOWEG | $18,970,160 | (Sep 17, 2025)
Plumerai | $8,700,000 | (Sep 17, 2025)
Hiverge | $5,000,000 | (Sep 17, 2025)
uiAgent | $4,600,000 | (Sep 16, 2025)